X

Trial Profile

Hunter Outcome Survey: A Global, Multi-Center, Long-Term, Observational Registry of Patients With Hunter Syndrome (Mucopolysaccharidosis Type II, MPS II)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 14 Feb 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Idursulfase (Primary)
Indications Mucopolysaccharidosis II
Focus Adverse reactions; Therapeutic Use
Acronyms HOS
Sponsors Shire; Takeda

Most Recent Events

27 Feb 2023 Status changed from recruiting to completed.
07 Nov 2022 Planned End Date changed from 31 Oct 2022 to 16 Feb 2023.
07 Nov 2022 Planned primary completion date changed from 31 Oct 2022 to 16 Feb 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com